Fig. 2

Observed AMR prevalence trends among 30-day non-duplicate Klebsiella spp. isolates from US female outpatients. Data for NTF NS are not depicted to provide greater clarity for the five other AMR phenotypes (NTF NS prevalence was > 50.0% throughout; these data can be found in Additional file 1: Fig. S2). AMR, Antimicrobial resistance; ESBL+/NS, Extended spectrum β-lactamase-producing or not susceptible to ceftriaxone, cefotaxime, ceftazidime, or cefepime; FQ, Fluoroquinolone; MDR-2/-3, Multidrug-resistant if resistant to ≥ 1 antibiotic in ≥ 2 or ≥ 3 drug classes (including NTF, SXT, FQ, or the ESBL+/NS phenotype); NS, not susceptible; NTF, Nitrofurantoin; SXT, Trimethoprim-sulfamethoxazole; US, United States